Senate Health Committee Chair Sanders: Ahead of Novo Nordisk Hearing, 250 Clinicians Demand Affordable Access to Ozempic, Wegovy
September 17, 2024
September 17, 2024
WASHINGTON, Sept. 17 -- Sen. Bernie Sanders, I-Vermont, chair of the Senate Health, Education, Labor and Pensions Committee, issued the following news release:
Ahead of next week's hearing, which will focus on the outrageously high prices that Novo Nordisk charges Americans for their blockbuster drugs, Ozempic and Wegovy, Sen. Bernie Sanders (I-Vt.), Chairman of the Senate Committee on Health, Education, Labor and Pensions (HELP), announced today that more than 250 clinicians f . . .
Ahead of next week's hearing, which will focus on the outrageously high prices that Novo Nordisk charges Americans for their blockbuster drugs, Ozempic and Wegovy, Sen. Bernie Sanders (I-Vt.), Chairman of the Senate Committee on Health, Education, Labor and Pensions (HELP), announced today that more than 250 clinicians f . . .